Shares of Roka Bioscience, Inc. (NASDAQ:ROKA) were down 0% during mid-day trading on Tuesday . The stock traded as low as $1.06 and last traded at $1.10. Approximately 626,602 shares were traded during trading, a decline of 70% from the average daily volume of 2,080,000 shares. The stock had previously closed at $1.10.

In related news, major shareholder Orbimed Advisors Llc sold 75,276 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $1.52, for a total value of $114,419.52. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In the last ninety days, insiders sold 894,570 shares of company stock worth $741,435. 29.20% of the stock is owned by corporate insiders.

A hedge fund recently bought a new stake in Roka Bioscience stock. AWM Investment Company Inc. acquired a new position in shares of Roka Bioscience, Inc. (NASDAQ:ROKA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 132,297 shares of the medical research company’s stock, valued at approximately $352,000. AWM Investment Company Inc. owned approximately 2.64% of Roka Bioscience at the end of the most recent quarter. 66.50% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at

About Roka Bioscience

Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Receive News & Stock Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related stocks with our FREE daily email newsletter.